Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edoxaban in multiple myeloma patients with venous thromboembolism
ChiCTR2500103822Phase 4Recruiting
- Sponsor
- Beijing Jishuitan Hospital
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of edoxaban in venous thromboembolism (VTE), sponsored by Beijing Jishuitan Hospital. Primary endpoints: Bleeding events, Blood coagulation function and 1 more. Started Jun 2025; status: recruiting.
02
Drugs
edoxaban
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on ChiCTR2500103822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500103822.